News | PET Imaging | January 25, 2017

Researchers use radiotracer that binds to mature olfactory sensory neurons to quantify neuronal populations

January 25, 2017 — In work published this week in the Journal of Clinical Investigation (JCI), a team led by Jacob Hooker at Harvard Medical School assessed GV1-57, a radiotracer that specifically binds to mature olfactory sensory neurons, as an approach for quantifying neuronal populations with positron emission tomography (PET) imaging.

Olfactory neurons in the nasal cavity are the primary source of our sense of smell. Unlike many types of neurons, olfactory neurons are continuously generated throughout the adult lifespan. This uniquely high rate of neuronal birth and death makes olfactory neurons particularly sensitive to the detrimental effects of progressive neurodevelopmental and neurodegenerative disease. In Alzheimer's disease and Parkinson's disease, loss of the sense of smell often precedes classical symptoms of cognitive or motor dysfunction. Therefore, a technique that is able to non-invasively quantify the olfactory neuron population could provide important insights related to the diagnosis and progression of neurodevelopmental and neurodegenerative diseases.

Using GV1-57, researchers were able to detect neuron generation during rodent postnatal development as well as neuron degeneration in rodent models of aging and neurodegenerative disease. In an additional proof-of-concept experiment, they showed that GV1-57 maintained saturable binding in non-human primate nasal cavity, suggesting that this radiotracer may be useful for evaluating neurological disease in clinical settings.

For more information: www.jci.org

Van de Bittner, G.C., Riley, M.M., Cao, L., Ehses, J., et al. "Nasal neuron PET imaging quantifies neuron generation and degeneration," The Journal of Clinical Invesigation. Published Jan. 23, 2017. doi:10.1172/JCI89162

Related Content

News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Time October 06, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

September 20, 2021 — Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging (MRI) to ...

Time September 20, 2021
arrow
News | Radiation Oncology

September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and ...

Time September 17, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 17, 2021
arrow
Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

Time September 16, 2021
arrow
Feature | PET Imaging | By Todd Sasser, Ph.D.

The use of positron emission tomography (PET) imaging in preclinical oncology investigations has shown the ability to ...

Time September 14, 2021
arrow
News | PET Imaging

September 13, 2021 — Lantheus Holdings, Inc. and RefleXion Medical, Inc., today announced a development and ...

Time September 13, 2021
arrow
News | RSNA

September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical ...

Time September 13, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 10, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time September 10, 2021
arrow
Subscribe Now